Last ¥1,679 JPY
Change Today -3.00 / -0.18%
Volume 90.7K
As of 2:00 AM 08/20/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for taiko pharmaceutical co ltd (4574)

Year over year, Taiko Pharmaceutical Co., Ltd. has been able to grow revenues from ¥7.4B JPY to ¥9.9B JPY. Most impressively, the company has been able to reduce the percentage of sales devoted to selling, general and administrative costs from 52.22% to 46.17%. This was a driver that led to a bottom line growth from ¥1.0B JPY to ¥1.7B JPY.
View Income Statement In U.S. Dollar
Currency in
Millions of Japanese Yens
As of:Mar 31
2011
JPY
Mar 31
2012
JPY
Mar 31
2013
JPY
Mar 31
2014
JPY
4 Year
Trend
Revenues4,619.06,683.07,443.09,947.0
TOTAL REVENUES4,619.06,683.07,443.09,947.0
Cost of Goods Sold1,733.02,194.02,436.02,763.0
GROSS PROFIT2,886.04,489.05,007.07,184.0
Selling General & Admin Expenses, Total4,128.03,974.03,887.04,593.0
OTHER OPERATING EXPENSES, TOTAL4,128.03,974.03,887.04,593.0
OPERATING INCOME-1,242.0515.01,120.02,591.0
Interest and Investment Income4.03.04.06.0
NET INTEREST EXPENSE4.03.04.06.0
Currency Exchange Gains (Loss)-40.09.073.066.0
Other Non-Operating Income (Expenses)85.032.014.019.0
EBT, EXCLUDING UNUSUAL ITEMS-1,193.0559.01,211.02,682.0
Gain (Loss) on Sale of Investments-94.0------
Gain (Loss) on Sale of Assets-380.0---40.0--
Other Unusual Items, Total-329.0-144.0-71.0-129.0
Other Unusual Items-260.0-106.0-71.0-119.0
EBT, INCLUDING UNUSUAL ITEMS-1,996.0415.01,100.02,553.0
Income Tax Expense232.0-67.063.0806.0
Earnings from Continuing Operations-2,228.0482.01,037.01,747.0
NET INCOME-2,228.0482.01,037.01,747.0
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-2,228.0482.01,037.01,747.0
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-2,228.0482.01,037.01,747.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4574:JP ¥1,679.00 JPY -3.00

4574 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4574.
View Industry Companies
 

Industry Analysis

4574

Industry Average

Valuation 4574 Industry Range
Price/Earnings 13.1x
Price/Sales 2.3x
Price/Book 2.0x
Price/Cash Flow 13.2x
TEV/Sales 1.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TAIKO PHARMACEUTICAL CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.